These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10204048)

  • 1. A review of Chlamydia pneumoniae and atherosclerosis.
    Lindholt JS; Fasting H; Henneberg EW; Ostergaard L
    Eur J Vasc Endovasc Surg; 1999 Apr; 17(4):283-9. PubMed ID: 10204048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of macrolide treatment of atherosclerosis and abdominal aortic aneurysms.
    Lindholt JS; Stovring J; Andersen PL; Henneberg EW; Østergaard L
    Curr Drug Targets Infect Disord; 2003 Mar; 3(1):55-63. PubMed ID: 12570733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlamydia pneumoniae detection in atherosclerotic plaques in Italy.
    Blasi F; Fagetti L; Allegra L
    J Infect Dis; 2000 Jun; 181 Suppl 3():S444-6. PubMed ID: 10839734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of chronic Chlamydia infection with non-specific inflammation on cardiovascular complications in acute myocardial infarct].
    Jaber AJ; Murín J; Hricák V; Tomasovic B; Kinová S; Kozlíková K; Ghanem W; Radman A
    Vnitr Lek; 2003 Feb; 49(2):109-14. PubMed ID: 12728577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chlamydia pneumoniae--chronic infection and atherosclerosis].
    Tiran B
    Wien Med Wochenschr; 2001; 151(24):590-3. PubMed ID: 11820175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chlamydia pneumoniae and atherosclerosis].
    Fortini A; Corti G; Cappelletti C
    Ann Ital Med Int; 1999; 14(4):253-63. PubMed ID: 10638018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chlamydia pneumoniae as a causative agent in atherosclerosis].
    van Deventer SJ
    Ned Tijdschr Geneeskd; 1999 Feb; 143(6):288-90. PubMed ID: 10221082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chlamydia pneumoniae and atherosclerosis].
    Andreasen JJ
    Ugeskr Laeger; 1997 Sep; 159(37):5503-7. PubMed ID: 9312918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlamydia pneumoniae in atherosclerotic tissue.
    Taylor-Robinson D; Thomas BJ
    J Infect Dis; 2000 Jun; 181 Suppl 3():S437-40. PubMed ID: 10839732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlamydia pneumoniae eradication from carotid plaques. Results of an open, randomised treatment study.
    Melissano G; Blasi F; Esposito G; Tarsia P; Dordoni L; Arosio C; Tshomba Y; Fagetti L; Allegra L; Chiesa R
    Eur J Vasc Endovasc Surg; 1999 Oct; 18(4):355-9. PubMed ID: 10550273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atherosclerosis and Chlamydia pneumoniae].
    Larsen MM; Mørn B; Andersen PL; Østergaard LJ
    Ugeskr Laeger; 2002 Dec; 164(50):5920-4. PubMed ID: 12553110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydia pneumoniae and vascular disease.
    Gibbs RG; Carey N; Davies AH
    Br J Surg; 1998 Sep; 85(9):1191-7. PubMed ID: 9752857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlamydia pneumoniae and atherosclerosis--an update.
    Saikku P
    Scand J Infect Dis Suppl; 1997; 104():53-6. PubMed ID: 9259083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherosclerosis and infection due to Chlamydia pneumoniae or cytomegalovirus: weighing the evidence.
    High KP
    Clin Infect Dis; 1999 Apr; 28(4):746-9. PubMed ID: 10825031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlamydia pneumoniae and atherosclerosis.
    Ouchi K
    Jpn J Infect Dis; 1999 Dec; 52(6):223-7. PubMed ID: 10738358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlamydia pneumoniae infections in mouse models: relevance for atherosclerosis research.
    de Kruif MD; van Gorp EC; Keller TT; Ossewaarde JM; ten Cate H
    Cardiovasc Res; 2005 Feb; 65(2):317-27. PubMed ID: 15639470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis.
    Grayston JT
    J Infect Dis; 2000 Jun; 181 Suppl 3():S402-10. PubMed ID: 10839724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary prevention of atherosclerosis through chlamydia pneumoniae eradication (SPACE Trial): a randomised clinical trial in patients with peripheral arterial disease.
    Vainas T; Stassen FR; Schurink GW; Tordoir JH; Welten RJ; van den Akker LH; Kurvers HA; Bruggeman CA; Kitslaar PJ
    Eur J Vasc Endovasc Surg; 2005 Apr; 29(4):403-11. PubMed ID: 15749042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection with Chlamydia pneumoniae and atherosclerosis: a review.
    Movahed MR
    J S C Med Assoc; 1999 Aug; 95(8):303-8. PubMed ID: 10478518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlamydia pneumoniae in atherosclerotic carotid artery plaques: high prevalence among heavy smokers.
    Dobrilovic N; Vadlamani L; Meyer M; Wright CB
    Am Surg; 2001 Jun; 67(6):589-93. PubMed ID: 11409810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.